Medicare Patients ' Psoriasis, PsA Drug Costs Remain High Medicare Patients ' Psoriasis, PsA Drug Costs Remain High
Coverage of and access to biologics for psoriasis and psoriatic arthritis are compromised by out-of-pocket payments and prior authorization requirements.Medscape Medical News
Source: Medscape Dermatology Headlines - Category: Dermatology Tags: Dermatology News Source Type: news
More News: Arthritis | Dermatology | Medicare | Psoriasis | Psoriatic Arthritis | Rheumatology | Skin